Announcements Trials

Browse Landscape

Phase

Phase 4 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1

Interventions

Whole-Body Irradiation 4 Peripheral Blood Stem Cell Transplantation 4 Mycophenolic Acid 3 Etoposide 3 Drug Therapy 3 Cyclosporine 3 fludarabine phosphate 2 Melphalan 2 Carmustine 2 plerixafor 1 monomethyl auristatin E 1 Vinorelbine 1 VAP-cyclo protocol 1 Thiotepa 1 O(6)-benzylguanine 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Leukapheresis 1 Immunoconjugates 1 Granulocyte Colony-Stimulating Factor 1 Gemcitabine 1 Filgrastim 1 Cytarabine 1 Cyclophosphamide 1 Carboplatin 1 Busulfan 1 Brentuximab Vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma, T-Cell, Peripheral × VAP-cyclo protocol × Clear all

NCT03268889 2017-08-31

CHOP

The First Affiliated Hospital of Soochow University

Phase NA Unknown

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡